SI2170831T1 - Benzazepinski derivati, uporabni kot antagonisti vazopresina - Google Patents

Benzazepinski derivati, uporabni kot antagonisti vazopresina

Info

Publication number: SI2170831T1
Authority: SI; Slovenia
Prior art keywords: derivatives useful; vasopressin antagonists; benzazepine derivatives; benzazepine; vasopressin
Prior art date: 2007-06-26

Application number

SI200830557T

Other languages

English (en)

Inventor

Kazumi Kondo

Yasuhiro Menjo

Takahiro Tomoyasu

Shin Miyamura

Yuso Tomohira

Takakuni Matsuda

Keigo Yamada

Yusuke Kato

Original Assignee

Otsuka Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-26

Filing date

2008-06-26

Publication date

2012-04-30

2008-06-26 Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd

2012-04-30 Publication of SI2170831T1 publication Critical patent/SI2170831T1/sl

Links

229940116211 Vasopressin antagonist Drugs 0.000 title 1
150000008038 benzoazepines Chemical class 0.000 title 1
239000003038 vasopressin antagonist Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/5532—Seven-(or more) membered rings
- C07F9/5535—Seven-(or more) membered rings condensed with carbocyclic rings or ring systems
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SI200830557T 2007-06-26 2008-06-26 Benzazepinski derivati, uporabni kot antagonisti vazopresina SI2170831T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2007167207		2007-06-26
PCT/JP2008/062033 WO2009001968A1 (en)	2007-06-26	2008-06-26	Benzazepine derivatives useful as vasopressin antagonists
EP08765871A EP2170831B1 (en)	2007-06-26	2008-06-26	Benzazepine derivatives useful as vasopressin antagonists

Publications (1)

Publication Number	Publication Date
SI2170831T1 true SI2170831T1 (sl)	2012-04-30

Family

ID=39773045

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
SI200831177T SI2374797T1 (sl)	2007-06-26	2008-06-26	Benzazepinski derivati, uporabni kot antagonisti vazopresina
SI200830557T SI2170831T1 (sl)	2007-06-26	2008-06-26	Benzazepinski derivati, uporabni kot antagonisti vazopresina
SI200831051T SI2374798T1 (sl)	2007-06-26	2008-06-26	Benzazepinski derivati, uporabni kot antagonisti vazopresina

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SI200831177T SI2374797T1 (sl)	2007-06-26	2008-06-26	Benzazepinski derivati, uporabni kot antagonisti vazopresina

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SI200831051T SI2374798T1 (sl)	2007-06-26	2008-06-26	Benzazepinski derivati, uporabni kot antagonisti vazopresina

Country Status (27)

Country	Link
US (3)	US8669229B2 (sl)
EP (3)	EP2374797B1 (sl)
JP (3)	JP5653043B2 (sl)
KR (1)	KR101487201B1 (sl)
CN (3)	CN103342680A (sl)
AR (1)	AR067176A1 (sl)
AT (1)	ATE545633T1 (sl)
AU (1)	AU2008269918B2 (sl)
BR (1)	BRPI0813768A2 (sl)
CA (1)	CA2690335A1 (sl)
CO (1)	CO6160295A2 (sl)
CY (3)	CY1113519T1 (sl)
DK (3)	DK2374798T3 (sl)
ES (3)	ES2460018T3 (sl)
HK (3)	HK1163077A1 (sl)
HR (3)	HRP20120310T1 (sl)
IL (1)	IL202561A0 (sl)
MY (3)	MY152805A (sl)
NZ (3)	NZ581723A (sl)
PL (3)	PL2374798T3 (sl)
PT (3)	PT2170831E (sl)
RU (1)	RU2471784C2 (sl)
SG (2)	SG182231A1 (sl)
SI (3)	SI2374797T1 (sl)
TW (1)	TWI459947B (sl)
UA (1)	UA98966C2 (sl)
WO (1)	WO2009001968A1 (sl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI459947B (zh) *	2007-06-26	2014-11-11	Otsuka Pharma Co Ltd	苯并氮呯化合物及藥學製劑
JP5656399B2 (ja) *	2008-12-26	2015-01-21	大塚製薬株式会社	医薬及び医薬製剤
CN102030709B (zh) *	2009-09-25	2013-10-16	江苏豪森医药集团有限公司	用作加压素受体拮抗剂的苯并氮杂卓类化合物
EA022253B1 (ru)	2009-10-26	2015-11-30	Оцука Фармасьютикал Ко., Лтд.	Соединение бензазепина и его применения
GB201105537D0 (en)	2011-03-31	2011-05-18	Vantia Ltd	New process
CN102260213B (zh) *	2011-05-31	2013-05-15	重庆福安药业(集团)股份有限公司	一种托伐普坦的制备方法
TWI704919B (zh)	2012-05-31	2020-09-21	日商大塚製藥股份有限公司	用於預防及/或治療多囊性腎臟病之藥物
CA2894516A1 (en) *	2012-12-28	2014-07-03	Otsuka Pharmaceutical Co., Ltd.	Injectable depot formulation comprising optically active tolvaptan and process of producing the same
US9505737B2 (en)	2013-01-11	2016-11-29	Corsair Pharma, Inc.	Treprostinil derivative compounds and methods of using same
TWI660748B (zh) *	2013-03-01	2019-06-01	日商大塚製藥股份有限公司	用於口服投藥之包含非晶型托伐普坦（Ｔｏｌｖａｐｔａｎ）的懸浮液
TW201605488A (zh)	2013-10-15	2016-02-16	大塚製藥股份有限公司	用以預防及／或治療多囊腎病之藥物
US11911369B2 (en) *	2015-03-03	2024-02-27	Biohaven Therapeutics Ltd.	Prodrugs of riluzole and their method of use
WO2019003433A1 (ja) *	2017-06-30	2019-01-03	大塚製薬株式会社	ベンゾアゼピン誘導体
CN107540672A (zh) *	2017-10-10	2018-01-05	牡丹江医学院	一种治疗肝硬化的药物及其合成方法
HU231206B1 (hu)	2017-12-15	2021-10-28	Richter Gedeon Nyrt.	Triazolobenzazepinek
TW201938171A (zh)	2017-12-15	2019-10-01	匈牙利商羅特格登公司	作為血管升壓素Ｖ１ａ受體拮抗劑之三環化合物
JP2020011957A (ja) *	2019-07-22	2020-01-23	コルセアファーマインコーポレイテッド	トレプロスチニル誘導体化合物およびその使用方法
CN112851583B (zh) *	2021-01-19	2023-09-08	徐州医科大学	新型苯并氮杂䓬类化合物、组合物及其用途
WO2022171160A1 (zh)	2021-02-10	2022-08-18	上海森辉医药有限公司	苯并氮杂䓬类化合物及其制备方法和医药用途
CN113112528A (zh) *	2021-04-26	2021-07-13	中南财经政法大学	异常行为监控方法、装置、设备及存储介质

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5045478A (en) *	1986-03-03	1991-09-03	Becton Dickinson And Company	Vesicles and use thereof in an assay
US5258510A (en) *	1989-10-20	1993-11-02	Otsuka Pharma Co Ltd	Benzoheterocyclic compounds
TW249201B (sl)	1992-07-02	1995-06-11	Otsuka Pharma Co Ltd
TW270927B (sl) *	1992-10-16	1996-02-21	Otsuka Pharma Co Ltd
GB9726695D0 (en)	1997-12-17	1998-02-18	Smithkline Beecham Plc	Novel compounds
JP4210355B2 (ja)	1997-07-03	2009-01-14	大塚製薬株式会社	固形製剤組成物
WO2000018761A1 (en)	1998-09-29	2000-04-06	American Cyanamid Company	Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
DE60102815D1 (de) *	2000-05-15	2004-05-19	Paratek Pharm Innc	7-substituierte kondensierte ring-tetrazyclin- verbindungen
EP1812039A1 (en)	2004-11-02	2007-08-01	New River Pharmaceuticals Inc.	Prodrugs of ribavirin with improved hepatic delivery
AU2006330277B2 (en) *	2005-12-27	2011-10-06	Otsuka Pharmaceutical Co., Ltd.	Water-soluble benzoazepine compound and its pharmaceutical composition
TWI459947B (zh) *	2007-06-26	2014-11-11	Otsuka Pharma Co Ltd	苯并氮呯化合物及藥學製劑

2008
- 2008-06-24 TW TW097123513A patent/TWI459947B/zh active
- 2008-06-26 AU AU2008269918A patent/AU2008269918B2/en not_active Ceased
- 2008-06-26 EP EP11172828.3A patent/EP2374797B1/en not_active Not-in-force
- 2008-06-26 ES ES11172828.3T patent/ES2460018T3/es active Active
- 2008-06-26 EP EP11172829.1A patent/EP2374798B1/en not_active Not-in-force
- 2008-06-26 PT PT08765871T patent/PT2170831E/pt unknown
- 2008-06-26 MY MYPI20124513 patent/MY152805A/en unknown
- 2008-06-26 ES ES08765871T patent/ES2380085T3/es active Active
- 2008-06-26 EP EP08765871A patent/EP2170831B1/en not_active Not-in-force
- 2008-06-26 SI SI200831177T patent/SI2374797T1/sl unknown
- 2008-06-26 DK DK11172829.1T patent/DK2374798T3/da active
- 2008-06-26 MY MYPI20124514 patent/MY150941A/en unknown
- 2008-06-26 CN CN2013101949565A patent/CN103342680A/zh active Pending
- 2008-06-26 AR ARP080102749A patent/AR067176A1/es unknown
- 2008-06-26 NZ NZ581723A patent/NZ581723A/en not_active IP Right Cessation
- 2008-06-26 NZ NZ598067A patent/NZ598067A/xx not_active IP Right Cessation
- 2008-06-26 RU RU2010102229/04A patent/RU2471784C2/ru not_active IP Right Cessation
- 2008-06-26 CN CN2013101948844A patent/CN103342679A/zh active Pending
- 2008-06-26 PL PL11172829T patent/PL2374798T3/pl unknown
- 2008-06-26 PT PT111728283T patent/PT2374797E/pt unknown
- 2008-06-26 AT AT08765871T patent/ATE545633T1/de active
- 2008-06-26 SI SI200830557T patent/SI2170831T1/sl unknown
- 2008-06-26 BR BRPI0813768-4A2A patent/BRPI0813768A2/pt not_active IP Right Cessation
- 2008-06-26 WO PCT/JP2008/062033 patent/WO2009001968A1/en active Application Filing
- 2008-06-26 PL PL11172828T patent/PL2374797T3/pl unknown
- 2008-06-26 UA UAA201000653A patent/UA98966C2/ru unknown
- 2008-06-26 PT PT111728291T patent/PT2374798E/pt unknown
- 2008-06-26 JP JP2009553349A patent/JP5653043B2/ja not_active Expired - Fee Related
- 2008-06-26 SI SI200831051T patent/SI2374798T1/sl unknown
- 2008-06-26 NZ NZ598064A patent/NZ598064A/xx not_active IP Right Cessation
- 2008-06-26 MY MYPI20095341A patent/MY148312A/en unknown
- 2008-06-26 SG SG2012047064A patent/SG182231A1/en unknown
- 2008-06-26 DK DK08765871.2T patent/DK2170831T3/da active
- 2008-06-26 KR KR20107001719A patent/KR101487201B1/ko not_active IP Right Cessation
- 2008-06-26 CA CA2690335A patent/CA2690335A1/en not_active Abandoned
- 2008-06-26 CN CN200880022253A patent/CN101687805A/zh active Pending
- 2008-06-26 SG SG2012047056A patent/SG182230A1/en unknown
- 2008-06-26 ES ES11172829T patent/ES2431515T3/es active Active
- 2008-06-26 US US12/666,751 patent/US8669229B2/en not_active Expired - Fee Related
- 2008-06-26 PL PL08765871T patent/PL2170831T3/pl unknown
- 2008-06-26 DK DK11172828.3T patent/DK2374797T3/da active
2009
- 2009-12-07 IL IL202561A patent/IL202561A0/en unknown
2010
- 2010-01-26 CO CO10007691A patent/CO6160295A2/es unknown
- 2010-09-06 HK HK12103584.2A patent/HK1163077A1/xx not_active IP Right Cessation
- 2010-09-06 HK HK10108445.2A patent/HK1141994A1/xx not_active IP Right Cessation
- 2010-09-06 HK HK12103585.1A patent/HK1163660A1/xx not_active IP Right Cessation
2012
- 2012-04-10 HR HRP20120310AT patent/HRP20120310T1/hr unknown
- 2012-05-04 CY CY20121100415T patent/CY1113519T1/el unknown
2013
- 2013-09-24 US US14/034,943 patent/US8785386B2/en not_active Expired - Fee Related
- 2013-09-24 US US14/034,979 patent/US9073868B2/en not_active Expired - Fee Related
- 2013-10-10 CY CY20131100894T patent/CY1114491T1/el unknown
- 2013-11-18 HR HRP20131095AT patent/HRP20131095T1/hr unknown
2014
- 2014-05-30 HR HRP20140501AT patent/HRP20140501T1/hr unknown
- 2014-06-11 CY CY20141100426T patent/CY1115226T1/el unknown
- 2014-06-25 JP JP2014130326A patent/JP5689195B2/ja not_active Expired - Fee Related
- 2014-06-25 JP JP2014130327A patent/JP5893085B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DK2170831T3 (da)	2012-05-21
PL2374797T3 (pl)	2014-08-29
SG182231A1 (en)	2012-07-30
RU2471784C2 (ru)	2013-01-10
SI2374797T1 (sl)	2014-05-30
ES2380085T3 (es)	2012-05-08
HRP20120310T1 (hr)	2012-06-30
US20140024640A1 (en)	2014-01-23
US8669229B2 (en)	2014-03-11
EP2374797A1 (en)	2011-10-12
CA2690335A1 (en)	2008-12-31
BRPI0813768A2 (pt)	2014-12-30
AU2008269918A1 (en)	2008-12-31
JP5893085B2 (ja)	2016-03-23
PT2374798E (pt)	2013-11-05
CY1113519T1 (el)	2016-06-22
AR067176A1 (es)	2009-09-30
CN101687805A (zh)	2010-03-31
EP2170831A1 (en)	2010-04-07
AU2008269918B2 (en)	2012-12-06
HRP20131095T1 (hr)	2014-01-03
IL202561A0 (en)	2010-06-30
US9073868B2 (en)	2015-07-07
ES2431515T3 (es)	2013-11-26
JP2010531293A (ja)	2010-09-24
JP2014208680A (ja)	2014-11-06
CN103342680A (zh)	2013-10-09
TWI459947B (zh)	2014-11-11
MY150941A (en)	2014-03-14
EP2170831B1 (en)	2012-02-15
ATE545633T1 (de)	2012-03-15
NZ598067A (en)	2012-12-21
HK1141994A1 (en)	2010-11-26
PL2170831T3 (pl)	2012-08-31
ES2460018T3 (es)	2014-05-13
UA98966C2 (ru)	2012-07-10
SG182230A1 (en)	2012-07-30
EP2374797B1 (en)	2014-03-26
SI2374798T1 (sl)	2013-10-30
EP2374798B1 (en)	2013-09-04
KR20100040873A (ko)	2010-04-21
CN103342679A (zh)	2013-10-09
PL2374798T3 (pl)	2014-01-31
TW200911271A (en)	2009-03-16
CY1115226T1 (el)	2017-01-04
HRP20140501T1 (hr)	2014-07-04
NZ581723A (en)	2012-03-30
US20110071084A1 (en)	2011-03-24
MY152805A (en)	2014-11-28
US20140024619A1 (en)	2014-01-23
CO6160295A2 (es)	2010-05-20
EP2374798A1 (en)	2011-10-12
JP5689195B2 (ja)	2015-03-25
HK1163660A1 (en)	2012-09-14
HK1163077A1 (en)	2012-09-07
DK2374797T3 (da)	2014-05-12
MY148312A (en)	2013-03-29
CY1114491T1 (el)	2016-10-05
RU2010102229A (ru)	2011-08-10
JP5653043B2 (ja)	2015-01-14
NZ598064A (en)	2013-04-26
DK2374798T3 (da)	2013-10-07
US8785386B2 (en)	2014-07-22
PT2374797E (pt)	2014-05-02
JP2014205703A (ja)	2014-10-30
WO2009001968A1 (en)	2008-12-31
PT2170831E (pt)	2012-04-13
KR101487201B1 (ko)	2015-01-28

Publication	Publication Date	Title
HK1163077A1 (en)	2012-09-07	Benzazepine derivatives useful as vasopressin antagonists
IL239402A0 (en)	2015-07-30	Kinase antagonists
HK1163676A1 (en)	2012-09-14	Bicyclic heterocyclic compound
GB0722087D0 (en)	2007-12-19	Polyamides
HK1141803A1 (en)	2010-11-19	Quinoline-carboxamide derivatives as p2y12 antagonists
ZA200906812B (en)	2010-12-29	Crig antagonists
ZA200810683B (en)	2010-02-24	C-phenyl 1-thioglucitol compound
EP2054434A4 (en)	2011-07-13	ANTAGONISTS AGAINST MYOSTATIN
EP2138482A4 (en)	2011-06-15	BICYCLIC HETEROCYCLIC COMPOUND
IL206402A0 (en)	2010-12-30	Bicyclic heterocyclic derivative
EP2200774A4 (en)	2014-09-10	MEHRZWECKFACETTIERMASCHINE
EP2221308A4 (en)	2011-06-22	BENZAZEPINONE COMPOUND
IL202339A0 (en)	2010-06-30	Azacyclylbenzamide derivatives as histamine-3 antagonists
EP2120564A4 (en)	2011-05-04	BENZAZEPINE COMPOUNDS AS CGRP RECEPTOR ANTAGONISTS
ZA200802339B (en)	2009-10-28	Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
ZA201003169B (en)	2011-04-28	New non-peptide derivatives as bradykinin b1 antagonists
EP2154139A4 (en)	2012-01-04	BICYCLIC HETEROCYCLIC COMPOUND
GB201000798D0 (en)	2010-03-03	Poly-TLR antagonists
ZA201202150B (en)	2012-11-28	[1,4]-benzodiazepines as vasopressin v2 receptor antagonists
IL201721A0 (en)	2010-05-31	Isoquinolinone derivatives as nk3 antagonists